Activation of [alpha]1A-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing

Background and Purpose A NO-mediated desensitization of vasoconstrictor responses evoked by stimulation of [alpha]1-adrenoceptors has been reported in different vessels. We investigated the involvement of each [alpha]1-adrenoceptor subtype and constitutive NOS isoforms and the influence of ageing an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2017-07, Vol.174 (13), p.2015
Hauptverfasser: Arce, Cristina, Vicente, Diana, Segura, Vanessa, Flacco, Nicla, Monto, Fermi, Almenar, Luis, Aguero, Jaime, Rueda, Joaquín, Jimenez-Altayo, Francesc, Vila, Elisabet, Noguera, Maria Antonia, D'Ocon, Pilar, Ivorra, Maria Dolores
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Purpose A NO-mediated desensitization of vasoconstrictor responses evoked by stimulation of [alpha]1-adrenoceptors has been reported in different vessels. We investigated the involvement of each [alpha]1-adrenoceptor subtype and constitutive NOS isoforms and the influence of ageing and hypertension on this process. Experimental Approach Wistar and spontaneously hypertensive rats (SHR), 16, 32, 52 and 72 weeks-old, were used to evaluate the desensitization process. Expression of [alpha]1-adrenoceptor subtypes, endothelial NOS (eNOS) and neuronal NOS (nNOS) were determined in rat aorta and left ventricle (LV). Expression levels were also evaluated in LV of a group of heart failure patients with a wide age range. Key Results Repeated application of phenylephrine decreased subsequent [alpha]1-adrenoceptor-mediated vasoconstriction by increasing nNOS protein expression in aorta, but not in tail or mesenteric resistance arteries, where mRNA levels of nNOS were undetectable. This desensitization process disappeared in the absence of endothelium or in the presence of L-NAME (100 µM), nNOS inhibitors, SMTC (1 µM) and TRIM (100 µM), and 5-methylurapidil (100 nM, [alpha]1A-antagonist), but not BMY7378 (10 nM, [alpha]1D-antagonist). The [alpha]1A/nNOS-mediated desensitization was absent in aged SHR and Wistar animals, where the expression of [alpha]1A-adrenoceptors was reduced in aorta and LV. In human LV, a negative correlation was found between age and [alpha]1A-adrenoceptor expression. Conclusions and Implications The [alpha]1A-adrenoceptor subtype, through endothelial nNOS-derived NO, may act as a physiological 'brake' against the detrimental effects of excessive [alpha]1-adrenoceptor-mediated vasoconstriction. Reduced [alpha]1A-adrenoceptor- and nNOS-mediated desensitization in aged patients could be involved in the age-dependent elevation of adrenergic activity.
ISSN:0007-1188
1476-5381
DOI:10.1111/bph.13800